Have a personal or library account? Click to login
Anticancer effects of 7,8-dihydromethysticin in human leukemia cells are mediated via cell-cycle dysregulation, inhibition of cell migration and invasion and targeting JAK/STAT pathway Cover

Anticancer effects of 7,8-dihydromethysticin in human leukemia cells are mediated via cell-cycle dysregulation, inhibition of cell migration and invasion and targeting JAK/STAT pathway

Acta Pharmaceutica
Volume 71 (2021): Issue 4 (December 2021)
By: Yi Xiao,  Taoran Deng,  Lijun Jiang and  Di Wang  
Open Access
|Apr 2021
DOI: https://doi.org/10.2478/acph-2021-0037 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 645 - 655
Accepted on: Oct 27, 2020
Published on: Apr 3, 2021
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
leukemia,
7,
8-dihydromethysticin,
flow cytometry,
cell cycle,
signalling pathway
Related subjects:
Pharmacy,
Pharmacy, other

© 2021 Yi Xiao, Taoran Deng, Lijun Jiang, Di Wang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 71 (2021): Issue 4 (December 2021)Next article